10-Q: Cinemark Reports Strong Revenue and Operating Income Growth Amid Film Slate Recovery, Reinstates Dividends

Cinemark Holdings, Inc. reported significant increases in revenue and operating income for the second quarter and first half of 2025, driven by a robust film slate and strategic pricing, while actively managing its debt and returning capital to shareholders.

Summary

• Total revenue for the six months ended June 30, 2025, increased by 12.8% to $1,481.2 million, up from $1,313.4 million in the prior year period.
• Admissions revenue grew by 11.5% to $731.2 million, and concession revenue increased by 13.7% to $588.1 million for the first half of 2025.
• Operating income for the six months ended June 30, 2025, surged by 53.5% to $154.3 million, compared to $100.5 million in the same period last year.
• Adjusted EBITDA for the six months ended June 30, 2025, rose by 26.2% to $268.6 million, up from $212.8 million in the prior year period.
• Net income attributable to Cinemark Holdings, Inc. for the six months ended June 30, 2025, was $54.6 million, a decrease from $70.6 million in the prior year, primarily due to a non-recurring deferred tax benefit in 2024.
• Diluted earnings per share for the six months ended June 30, 2025, was $0.38, down from $0.51 in the comparable 2024 period.
• U.S. attendance increased by 9.1% to 57.5 million patrons for the first half of 2025, driven by a stronger film slate.
• Average ticket price in the U.S. increased by 4.4% to $10.28, and concession revenue per patron increased by 5.5% to $8.21 for the six months ended June 30, 2025.
• The company completed a $200 million share repurchase program in March 2025.
• Quarterly cash dividends of $0.08 per common share were reinstated and paid in March and June 2025.
• The 4.50% Convertible Senior Notes, with an outstanding principal of $460.0 million, will mature and be repaid in cash on August 15, 2025, with amounts above principal settled in shares.
• CUSA amended its senior secured credit facility on June 30, 2025, reducing the term loan interest rate by 0.50% and resetting the 101% soft call for six months.
• An asset impairment charge of $1.6 million was recorded for three international theaters during the six months ended June 30, 2025.
• The company's Consolidated Net Total Leverage Ratio was 1.41 to 1.00 as of June 30, 2025, well below the covenant limit.

Sentiment

Score: 7

Explanation: The company demonstrates strong operational recovery with significant revenue and operating income growth, effective debt management, and a commitment to shareholder returns through dividends and share repurchases. While net income and EPS are lower due to a non-recurring tax benefit in the prior year, the underlying business performance is robust. Ongoing legal proceedings and an IRS audit present some uncertainty, but the overall financial health and strategic direction appear positive.

Positives

• Total revenue increased by 12.8% for the six months ended June 30, 2025, demonstrating strong top-line growth.
• Operating income saw a substantial 53.5% increase for the first half of 2025, indicating improved operational efficiency.
• Adjusted EBITDA grew by 26.2% to $268.6 million, reflecting robust underlying business performance.
• U.S. attendance rose by 9.1%, driven by a stronger film slate, signaling a recovery in consumer demand.
• Strategic pricing initiatives led to a 4.4% increase in U.S. average ticket price and a 5.5% increase in U.S. concession revenue per patron.
• The company successfully completed a $200 million share repurchase program, returning capital to shareholders.
• Quarterly cash dividends of $0.08 per common share were reinstated, indicating confidence in future cash flows.
• The senior secured credit facility was amended to reduce the term loan interest rate by 0.50%, lowering future interest expenses.
• Strong leverage ratios, with a Consolidated Net Total Leverage Ratio of 1.41 to 1.00 and an actual coverage ratio of 6.7 to 1, demonstrate financial health and flexibility.
• A gain on disposal of assets and other of $3.1 million was recorded for the six months ended June 30, 2025, from the sale of a land parcel and a theater property.
• The One Big Beautiful Bill Act (OBBBA) signed into law on July 4, 2025, may result in the release of a portion of the U.S. valuation allowance on deferred tax assets, potentially improving future financial results.

Negatives

• Net income attributable to Cinemark Holdings, Inc. decreased by 22.7% to $54.6 million for the six months ended June 30, 2025, compared to $70.6 million in the prior year.
• Diluted earnings per share decreased by 25.5% to $0.38 for the six months ended June 30, 2025, compared to $0.51 in the prior year.
• Cash and cash equivalents decreased by $125.7 million from December 31, 2024, to June 30, 2025, primarily due to financing activities.
• Cash provided by operating activities slightly decreased by 3.3% to $156.8 million for the six months ended June 30, 2025.
• Cash used for financing activities increased by 46.5% to $246.3 million, largely due to share repurchases and dividend payments.
• An asset impairment charge of $1.6 million was recorded for three international theaters that have not demonstrated sufficient recovery.
• Interest expense increased to $77.9 million for the six months ended June 30, 2025, up from $72.3 million in the prior year, due to new senior notes and amortization of accumulated losses for swap agreements.
• A net loss on investment in NCMI of $7.9 million was recorded for the six months ended June 30, 2025, compared to a net gain in the prior year.
• The company recorded a foreign currency exchange loss of $0.5 million for the six months ended June 30, 2025, primarily due to hyper-inflationary accounting for Argentina.
• The company is currently under an IRS audit for tax years 2019 and 2020, with a proposed income tax adjustment of $65.0 million before interest and penalties, which the company intends to vigorously defend.

Risks

• The success of the theatrical exhibition industry is highly contingent upon the volume and diversity of new film content available.
• The duration of exclusive theatrical release windows significantly impacts revenue.
• Competition from other exhibitors, alternative forms of entertainment, and content delivery via streaming and other formats poses an ongoing challenge.
• Changes in legislation, government regulations, or policies could adversely affect operations.
• Outcomes of ongoing lawsuits, including class action lawsuits related to the Fair and Accurate Credit Transactions Act, alleged mislabeling of draft beer cups, and California Labor Code violations, are uncertain.
• Extraordinary events beyond the company's control, such as conflicts, wars, natural disasters, public health crises, labor strikes, or terrorist acts, could impact business.
• Currency exchange rate fluctuations and inflationary pressures continue to impact product costs and wage rates.
• The ultimate outcome of the IRS audit for tax years 2019 and 2020 is uncertain, and there is no assurance it will be resolved favorably.
• The company's ability to recover its deferred tax assets is subject to future sources of taxable income and may require a valuation allowance if not realized.

Future Outlook

The company anticipates repaying the $460.0 million principal amount of its 4.50% Convertible Senior Notes in cash on their August 15, 2025, maturity date, with any amounts owed above the principal settled in shares. It expects to receive an equal and offsetting number of shares from hedge counterparties. Warrants are set to expire between November 15, 2025, and March 12, 2026, which may be settled in cash or shares. The company plans to fund future capital expenditures for development projects with cash flow from operations and, if necessary, borrowings under its senior secured credit facility, debt issuances, sale-leaseback transactions, and/or sales of excess real estate. The Board of Directors anticipates paying regular quarterly cash dividends on common stock, subject to available cash, needs, financial condition, and loan agreement restrictions. The company is currently assessing the impact of the One Big Beautiful Bill Act (OBBBA), signed into law on July 4, 2025, which may lead to the release of a portion of the U.S. valuation allowance on deferred tax assets.

Management Comments

• The success of the theatrical exhibition industry is contingent upon several key factors, including the volume of new film content available, which is continuing to recover from the effects of the COVID-19 pandemic and most recently the writers and actors guilds strikes, as well as the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment.
• We believe our existing cash and expected cash flows from operations will be sufficient to meet our working capital, capital expenditures, and known contractual obligations for the next twelve months and beyond.
• The company firmly disagrees with the conclusions presented by the IRS regarding the proposed income tax adjustment for tax years 2019 and 2020 and believes the positions reported on its tax returns that have not been reserved for are more likely than not to prevail on technical merits. The company intends to vigorously defend its reported positions through the applicable IRS administrative and judicial procedures, as appropriate.

Industry Context

The theatrical exhibition industry continues its recovery, benefiting from a stronger film slate following the impacts of the COVID-19 pandemic and recent Hollywood strikes. However, the industry faces ongoing competition from alternative entertainment forms and content delivery via streaming services. The company's performance reflects this recovery, with increased attendance and revenue, but also highlights the persistent challenges of managing costs amid inflationary pressures on product costs and wage rates.

Comparison to Industry Standards

• The filing does not provide specific comparable company data or industry benchmarks for direct comparison of financial metrics or operational performance. Analysis is primarily based on year-over-year internal performance and general industry trends mentioned within the document.

Legal Proceedings

• Gerardo Rodriguez, individually and on behalf of a class of all others similarly situated vs Cinemark USA, Inc. and Cinemark Holdings, Inc., et al.: Class action lawsuit filed February 24, 2023, alleging violation of the Fair and Accurate Credit Transactions Act. The company denies allegations and will vigorously defend.
• National CineMedia LLC Bankruptcy: Cinemark appealed a bankruptcy court order that failed to preserve its rights under the 'most favored nations' clause in its Exhibitor Services Agreement with NCM. The U.S. Fifth Circuit Court of Appeals affirmed lower court rulings, and Cinemark has decided not to appeal further.
• Shane Waldrop, individually and on behalf of all other similarly situated, vs. Cinemark USA, Inc.: Putative nationwide class action lawsuit filed April 16, 2024, alleging violations of the Federal Food Drug & Cosmetics Act, Texas Deceptive Trade Practices Act, negligent misrepresentation, fraud, and unjust enrichment related to alleged mislabeling of twenty-four ounce draft beer cups. The company denies allegations and will vigorously defend.
• Latishma Narayan, individually and on behalf of others similarly situated vs. Cinemark USA, Inc., Century Theatres, Inc., et al.: Class action lawsuit filed December 27, 2024, alleging violations of the California Labor Code for various wage and labor practices. The company denies contentions and will vigorously defend.
• IRS Audit for tax years 2019 and 2020: The IRS issued a revised Revenue Agent Report on June 11, 2025, proposing an income tax adjustment of $65.0 million (before interest and penalties). The company firmly disagrees and intends to vigorously defend its reported positions.

Related Party Transactions

• A subsidiary manages a theater for Laredo Theatre, Ltd., in which the company owns 75% of limited partnership interests. Management fees of $0.4 million were recorded for the six months ended June 30, 2025.
• Excess cash distributions of $0.4 million were paid to Lone Star Theatres, Inc. (owned by Lee Roy Mitchell's son-in-law) as required by the partnership agreement.
• A subsidiary leases 12 theaters from Syufy Enterprises, LP or its affiliates (Raymond Syufy is a director). Total rent paid was $11.0 million for the six months ended June 30, 2025.
• CUSA provides digital equipment support to drive-in theaters owned by Syufy, generating management fees of $0.03 million for the six months ended June 30, 2025.
• A subsidiary has a 50% voting interest in FE Concepts, a joint venture with AWSR (owned by Lee Roy Mitchell and Tandy Mitchell). CUSA receives service fees for film booking and equipment monitoring, totaling $0.03 million for the six months ended June 30, 2025.
• The company received a cash distribution of $4.0 million from FE Concepts during the six months ended June 30, 2025.

Stakeholder Impact

• Shareholders: Benefit from the reinstatement of quarterly cash dividends and the completion of a $200 million share repurchase program, indicating a commitment to returning capital. However, diluted EPS decreased due to a non-recurring tax benefit in the prior year.
• Employees: Wages and benefits inflation is noted, impacting salaries and wages expense, but labor productivity initiatives are in place. Share-based compensation continues to be a component of employee remuneration.
• Customers: Strategic pricing actions have led to higher average ticket prices and concession revenue per patron, potentially impacting affordability but also enhancing the value proposition through premium formats.
• Creditors: The company's proactive debt management, including interest rate reductions and strong leverage ratios (Consolidated Net Total Leverage Ratio of 1.41 to 1.00), indicates a healthy financial position and ability to meet debt obligations.
• Suppliers: The company sources products from a variety of partners globally to minimize supply chain interruptions and manage costs, indicating stable relationships.

Next Steps

• Repay $460.0 million principal amount of 4.50% Convertible Senior Notes in cash on August 15, 2025.
• Settle amounts owed above the principal of convertible notes in shares (estimated 17.0 million shares) on August 15, 2025.
• Receive an equal and offsetting number of shares (estimated 17.0 million shares) from hedge counterparties on August 15, 2025.
• Warrants will expire between November 15, 2025, and March 12, 2026, with potential settlement in cash or shares (estimated 8.8 million shares if settled in shares).
• Continue to fund capital expenditures for new and existing theaters with cash flow from operations and, if needed, borrowings under the senior secured credit facility, debt issuances, sale-leaseback transactions, and/or sales of excess real estate.
• Anticipate paying regular quarterly cash dividends on common stock, subject to Board discretion and financial conditions.
• Vigorously defend reported tax positions against the IRS audit for tax years 2019 and 2020 through administrative and judicial procedures.
• Evaluate the impact of the One Big Beautiful Bill Act (OBBBA) on consolidated financial statements, which may lead to a release of a portion of the U.S. valuation allowance on deferred tax assets.

Key Dates

Recommendation

Despite a reported decline in net income and EPS for the six-month period, which is clearly explained as being due to a non-recurring tax benefit in the prior year, the underlying operational performance of Cinemark is exceptionally strong. Revenue, operating income, and Adjusted EBITDA all show significant growth, driven by a recovering film slate and effective strategic pricing. The company's proactive financial management, including a successful share repurchase program, dividend reinstatement, and favorable debt refinancing, demonstrates a commitment to shareholder value and financial stability. The strong leverage ratios further underscore its robust financial health. The ongoing legal and tax matters are noted, but management expresses confidence in their defense. Given the positive operational momentum and shareholder-friendly actions, the stock appears undervalued relative to its recovery trajectory and financial discipline.

Keywords

Cinemark, CNK, SEC Filing, 10-Q, Quarterly Report, Financial Results, Movie Theater, Theatrical Exhibition, Box Office, Admissions Revenue, Concession Revenue, Operating Income, Adjusted EBITDA, Earnings Per Share, Dividends, Share Repurchase, Debt Management, Convertible Notes, Credit Facility, Film Slate, Industry Recovery, Inflation, Legal Proceedings, Tax Audit, Corporate Governance